Literature DB >> 22277631

Salvage prostatectomy post-definitive radiation therapy: The Vancouver experience.

Niall M Corcoran1, Guilherme Godoy1, Rodney C Studd1, Rowan G Casey1, Antonio Hurtado-Coll1, Scott Tyldesley2, S Larry Goldenberg1, Martin E Gleave1.   

Abstract

INTRODUCTION: Prostate cancer recurrence following primary radiation is common. If the recurrence remains localized to the prostate gland, surgical removal may result in long-term local control or cure. Despite the well-established oncological outcomes, salvage prostatectomy is infrequently performed or reported. We present our experience with salvage prostatectomy at a Canadian centre.
METHODS: We identified all patients undergoing salvage prostatectomy at the Vancouver General Hospital between 1995 and 2010 from a prospectively recorded and maintained prostate cancer database. Details regarding initial presentation, delivery of radiotherapy, clinical features at the time of recurrence, as well as oncological and functional outcomes, were collected. Information regarding postoperative morbidity was collected prospectively and confirmed by retrospective chart review.
RESULTS: Over a 15-year period, salvage prostatectomy was successfully completed in 21 patients. With a median follow-up period of 68 months (range: 2-122), 9 (43%) patients experienced a biochemical recurrence, with most failing within the first 2 years of surgery. There were 3 deaths in the cohort, all from prostate cancer, giving a prostate cancer specific and overall survival of 86%. The main postoperative morbidity was bladder neck contracture, occurring in 40%. One patient each developed a recto-urethral fistula and osteitis pubis. Physician-recorded data regarding continence was available in 13 (62%). Of these 13 patients, 10 (85%) men were recorded as dry or using 1 pad per day.
CONCLUSIONS: This is the first Canadian centre to report that salvage prostatectomy can be performed with favourable oncological and functional outcomes.

Entities:  

Year:  2013        PMID: 22277631      PMCID: PMC3650760          DOI: 10.5489/cuaj.11056

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  20 in total

1.  Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; J Fondurulia; M H Chen; I Kaplan; C J Beard; J E Tomaszewski; A A Renshaw; A Wein; C N Coleman
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

Review 2.  Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.

Authors:  Alessandro Sciarra; Jelle Barentsz; Anders Bjartell; James Eastham; Hedvig Hricak; Valeria Panebianco; J Alfred Witjes
Journal:  Eur Urol       Date:  2011-02-23       Impact factor: 20.096

3.  Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.

Authors:  M E Gleave; S L Goldenberg; J L Chin; J Warner; F Saad; L H Klotz; M Jewett; V Kassabian; M Chetner; C Dupont; S Van Rensselaer
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

4.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

Review 5.  The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.

Authors:  J Sylvester; P Grimm; J Blasco; R Meier; J Spiegel; C Heaney; W Cavanagh
Journal:  Urology       Date:  2001-08       Impact factor: 2.649

6.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

7.  Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes.

Authors:  John F Ward; Thomas J Sebo; Michael L Blute; Horst Zincke
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

8.  Radiation injury of the normal and neoplastic prostate.

Authors:  D G Bostwick; B M Egbert; L F Fajardo
Journal:  Am J Surg Pathol       Date:  1982-09       Impact factor: 6.394

9.  Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.

Authors:  Philippe Paparel; Angel M Cronin; Caroline Savage; Peter T Scardino; James A Eastham
Journal:  Eur Urol       Date:  2008-07-14       Impact factor: 20.096

Review 10.  Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature.

Authors:  Paul L Nguyen; Anthony V D'Amico; Andrew K Lee; W Warren Suh
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

View more
  5 in total

Review 1.  Management of Urethral Stricture and Bladder Neck Contracture Following Primary and Salvage Treatment of Prostate Cancer.

Authors:  Brendan Michael Browne; Alex J Vanni
Journal:  Curr Urol Rep       Date:  2017-10       Impact factor: 3.092

2.  Still unconvinced on the use of salvage prostatectomy.

Authors:  Laurence H Klotz
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

Review 3.  Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.

Authors:  Nicole M Golbari; Aaron E Katz
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

Review 4.  The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer.

Authors:  Steven A Tisseverasinghe; Juanita M Crook
Journal:  Transl Androl Urol       Date:  2018-06

Review 5.  Contemporary Management of Vesico-Urethral Anastomotic Stenosis After Radical Prostatectomy.

Authors:  Clemens M Rosenbaum; Margit Fisch; Malte W Vetterlein
Journal:  Front Surg       Date:  2020-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.